2 completed, 1 suspended. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Small Fiber Neuropathy: new trials by email Literature Review of Small Fiber Neuropathy trials Research Report on Small Fiber Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN) ST-503, Sham (No Treatment) - Chronic Neuropathic Pain | Phase 1 / Phase 2 | Suspended | Sangamo Therapeutics | 27 | 2025-12-04 | 2026-11-03 |
| Xanamem™ in Healthy Elderly Subjects Xanamem, Matching Placebo - Safety, Peripheral Neuropathy | Phase 1 | Completed | Actinogen Medical | 42 | 2019-01-21 | 2025-01-22 |
| Titration Study of ABX-1431 ABX-1431, Placebo oral capsule - Post Herpetic Neuralgia, Diabetic Peripheral Neuropathy | Phase 1 | Completed | Abide Therapeutics | 39 | 2017-10-02 | 2019-07-12 |
Neuralgia, Postherpetic (1) · Peripheral Nervous System Diseases (1)
Nervous System Diseases (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (2) · Neuralgia (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
ABX-1431 (1) · UE2343 (1) · salicylhydroxamic acid (1)
Abide Therapeutics (1) · Actinogen Medical (1) · Sangamo Therapeutics (1)
Australia (1) · Moldova (1) · United States (1)
Bill Ketelbey, MD (1) · Vitale Lisnic, PhD (1)